非酒精性脂肪性肝病患者的营养建议。
Nutritional recommendations for patients with non-alcoholic fatty liver diseases.
机构信息
Liver Unit, Faculty of Medicine, Ziv Medical Center, Safed 13100, Israel.
出版信息
World J Gastroenterol. 2011 Aug 7;17(29):3375-6. doi: 10.3748/wjg.v17.i29.3375.
Abstract
Fatty liver is the most common liver disease worldwide. Patients with fatty liver disease die primarily from cardiovascular disease and not from chronic liver diseases. Hyperglycemia and hyperinsulinemia induce lipogenesis, thereby increasing the hepatic pool of fatty acids. This pool is also increased by increased delivery of fatty acids through the diet or lipolysis in adipose tissue. Nutritional consultations and lifestyle modification are important in the treatment of non-alcoholic fatty liver disease (NAFLD). Among the dietary constituents, combination of vitamin D, vitamin E, and omega-3 fatty acids shows promise for the treatment of NAFLD.
摘要
脂肪肝是世界范围内最常见的肝脏疾病。脂肪肝患者的主要死亡原因是心血管疾病，而不是慢性肝脏疾病。高血糖和高胰岛素血症可诱导脂肪生成，从而增加肝脏脂肪酸池。通过饮食或脂肪组织中的脂肪分解增加脂肪酸的输送也会增加该池。营养咨询和生活方式改变是非酒精性脂肪性肝病（NAFLD）的重要治疗方法。在饮食成分中，维生素 D、维生素 E 和 ω-3 脂肪酸的组合显示出治疗 NAFLD 的潜力。
相似文献
1
Nutritional recommendations for patients with non-alcoholic fatty liver diseases.
World J Gastroenterol. 2011 Aug 7;17(29):3375-6. doi: 10.3748/wjg.v17.i29.3375.
2
Role of diet and nutritional management in non-alcoholic fatty liver disease.
J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:81-7. doi: 10.1111/jgh.12244.
3
Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence.
World J Gastroenterol. 2011 Aug 7;17(29):3377-89. doi: 10.3748/wjg.v17.i29.3377.
4
The role of diet and nutrient composition in nonalcoholic Fatty liver disease.
J Acad Nutr Diet. 2012 Mar;112(3):401-9. doi: 10.1016/j.jada.2011.10.007. Epub 2012 Mar 1.
5
Nonalcoholic fatty liver disease: a nutritional approach.
Metab Syndr Relat Disord. 2012 Jun;10(3):161-6. doi: 10.1089/met.2011.0145. Epub 2012 Mar 6.
6
Dietary habits and behaviors associated with nonalcoholic fatty liver disease.
World J Gastroenterol. 2014 Feb 21;20(7):1756-67. doi: 10.3748/wjg.v20.i7.1756.
7
[The role of diet in non-alcoholic fatty liver disease].
Korean J Gastroenterol. 2013 May;61(5):243-51. doi: 10.4166/kjg.2013.61.5.243.
8
The role of nutrition in non-alcoholic fatty liver disease treatment in obese children.
Arch Pediatr. 2022 Jan;29(1):1-11. doi: 10.1016/j.arcped.2021.09.009. Epub 2021 Nov 8.
9
Lean non-alcoholic fatty liver disease patients had comparable total caloric, carbohydrate, protein, fat, iron, sleep duration and overtime work as obese non-alcoholic fatty liver disease patients.
J Gastroenterol Hepatol. 2019 Jan;34(1):256-262. doi: 10.1111/jgh.14360. Epub 2018 Jul 16.
10
Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis.
Curr Vasc Pharmacol. 2018;16(3):239-245. doi: 10.2174/1570161115666170621080835.
引用本文的文献
1
The Effects of Probiotics and Omega-3 Fatty Acids in Liver Steatosis Induced in Rats by High-Fructose Corn Syrup.
Int J Clin Pract. 2022 Jan 31;2022:7172492. doi: 10.1155/2022/7172492. eCollection 2022.
2
Current therapies in alleviating liver disorders and cancers with a special focus on the potential of vitamin D.
Nutr Metab (Lond). 2018 Feb 9;15:13. doi: 10.1186/s12986-018-0251-5. eCollection 2018.
3
Genetics of non-alcoholic fatty liver disease: From susceptibility and nutrient interactions to management.
World J Hepatol. 2016 Jul 18;8(20):827-37. doi: 10.4254/wjh.v8.i20.827.
4
Mitochondrial dysfunction in obesity-associated nonalcoholic fatty liver disease: the protective effects of pomegranate with its active component punicalagin.
Antioxid Redox Signal. 2014 Oct 10;21(11):1557-70. doi: 10.1089/ars.2013.5538. Epub 2014 Feb 18.
5
How Much Weight Loss is Effective on Nonalcoholic Fatty Liver Disease?
Hepat Mon. 2013 Dec 7;13(12):e15227. doi: 10.5812/hepatmon.15227. eCollection 2013.
本文引用的文献
1
Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.
N Engl J Med. 2010 Sep 30;363(14):1341-50. doi: 10.1056/NEJMra0912063.
2
Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data.
Curr Opin Clin Nutr Metab Care. 2010 Nov;13(6):709-14. doi: 10.1097/MCO.0b013e32833f4b34.
3
Fructose and metabolic diseases: new findings, new questions.
Nutrition. 2010 Nov-Dec;26(11-12):1044-9. doi: 10.1016/j.nut.2010.02.014. Epub 2010 May 14.
4
Nonalcoholic fatty liver disease: pathology and pathogenesis.
Annu Rev Pathol. 2010;5:145-71. doi: 10.1146/annurev-pathol-121808-102132.
5
Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.
Hepatology. 2010 Feb;51(2):595-602. doi: 10.1002/hep.23314.
6
Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome.
J Hepatol. 2009 Nov;51(5):918-24. doi: 10.1016/j.jhep.2009.05.033. Epub 2009 Aug 21.
7
Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol.
Scand J Gastroenterol. 2009;44(4):471-7. doi: 10.1080/00365520802588133.
8
Fatty liver: a novel component of the metabolic syndrome.
Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):27-38. doi: 10.1161/ATVBAHA.107.147538. Epub 2007 Aug 9.
9
Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.
Hepatology. 2003 May;37(5):1202-19. doi: 10.1053/jhep.2003.50193.
Zotero 插件